|
|
muscle system process
|
GO:0003012 |
141 |
0.959
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.954
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.937
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.919
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.913
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.913
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.868
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.863
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.804
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.798
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.787
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.773
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.715
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.712
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.710
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.637
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.616
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.614
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.551
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.540
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.517
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.482
|
|
|
|
response to stimulus involved in regulation of muscle adaptation
|
GO:0014874 |
6 |
0.476
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.465
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.462
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.459
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.446
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.443
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.429
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.415
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.411
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.408
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.403
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.402
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.382
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.353
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.349
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.347
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.343
|
Mouse |
|
|
heart process
|
GO:0003015 |
94 |
0.330
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.312
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.309
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.292
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.285
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.269
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.265
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.261
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.260
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.247
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.242
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.240
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.228
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.226
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.219
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.215
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.211
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.208
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.206
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.203
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.200
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.198
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.198
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.190
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.190
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.183
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.180
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.180
|
Mouse |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.179
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.177
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.175
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.174
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.172
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.168
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.163
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.162
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.160
|
Mouse |
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.160
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.157
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.157
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.156
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.155
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.155
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.153
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.152
|
|
|
|
cell communication involved in cardiac conduction
|
GO:0086065 |
9 |
0.151
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.150
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.150
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.148
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.147
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.147
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.147
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.146
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.146
|
Mouse |
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.145
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.144
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.144
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.143
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.142
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.142
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.140
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.136
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.135
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.134
|
Mouse |
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.134
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.131
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.129
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.127
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.127
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.125
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.124
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.123
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.123
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.123
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.121
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.118
|
|
|
|
cardiac muscle cell action potential involved in contraction
|
GO:0086002 |
6 |
0.118
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.118
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.117
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.115
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.115
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.113
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.110
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.110
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.110
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.110
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.108
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.108
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.107
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.106
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.105
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.104
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.104
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.104
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.104
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.103
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.102
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.102
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.102
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.101
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.098
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.098
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.098
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.098
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.098
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.096
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.096
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.096
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.095
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.095
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.094
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.093
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.093
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.088
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.088
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.086
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.085
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.085
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.084
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.083
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.082
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.081
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.081
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.081
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.080
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.080
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.080
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.080
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.079
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.079
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.079
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.079
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.079
|
Mouse |
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.078
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.078
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.078
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.077
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.077
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
11 |
0.077
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.076
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.075
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.074
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.074
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.074
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.073
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.073
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.073
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.073
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.072
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.072
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.071
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.070
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.070
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.069
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.068
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.068
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.067
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.066
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.066
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.066
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.066
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.066
|
Mouse |
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.065
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.065
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.065
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.065
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.065
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.064
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.063
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.063
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.062
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.062
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.061
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.061
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.061
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.061
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.061
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.061
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.060
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.059
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.059
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.059
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.059
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.059
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.059
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.058
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.058
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.058
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.058
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.058
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.057
|
|
|
|
atrial septum development
|
GO:0003283 |
12 |
0.057
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.057
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.057
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.056
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.056
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.056
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.056
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.055
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.054
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.054
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.053
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.053
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.053
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.053
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.053
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.052
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.052
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.052
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.052
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.052
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.052
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.052
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.051
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.051
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.051
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.050
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.050
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.050
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.050
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.050
|
|
|
|
myotube differentiation involved in skeletal muscle regeneration
|
GO:0014908 |
2 |
0.049
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.049
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
11 |
0.048
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.048
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.047
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.047
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.047
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.047
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.047
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.047
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.046
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.046
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.046
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.046
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.046
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.046
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.046
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.045
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.045
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.045
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.045
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.045
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.045
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.045
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.045
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.045
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.045
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.044
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.044
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.044
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.044
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.044
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.044
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.044
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.044
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.043
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.043
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.043
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.042
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.042
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.042
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.042
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.042
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.042
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.042
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.042
|
|
|
|
skeletal muscle fiber adaptation
|
GO:0043503 |
1 |
0.041
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.041
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.041
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.041
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.041
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.041
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.041
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.041
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.041
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.041
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.041
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.041
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.040
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.040
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.040
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.040
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.040
|
|
|
|
sinoatrial node development
|
GO:0003163 |
4 |
0.040
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.040
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.040
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.040
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.039
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.039
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.039
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.039
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.039
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.039
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.038
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.038
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.038
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.038
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.038
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
12 |
0.038
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.038
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.038
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.038
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.037
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.037
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.037
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.037
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.037
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.037
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.037
|
|
|
|
regulation of membrane repolarization
|
GO:0060306 |
7 |
0.037
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.037
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.036
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.036
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.036
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.036
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.036
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.036
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.036
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.036
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.035
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.035
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.035
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.035
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.035
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.035
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.035
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.035
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.035
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.035
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.035
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.035
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.035
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.035
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.034
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.034
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.034
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.034
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.034
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.034
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.034
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.034
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.033
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.033
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.033
|
|
|
|
positive regulation of tongue muscle cell differentiation
|
GO:2001037 |
2 |
0.033
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.033
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.033
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.033
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.033
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.033
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.033
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.033
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.032
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.032
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.032
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.032
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.032
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.032
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.032
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.032
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.032
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.032
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.031
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.031
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.031
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.031
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.031
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.031
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.031
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.030
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.030
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.030
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.030
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.030
|
|
|
|
regulation of atrial cardiac muscle cell membrane depolarization
|
GO:0060371 |
5 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.030
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.030
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.030
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.030
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.030
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.030
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.030
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.030
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.030
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.030
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.030
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.030
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.030
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.030
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.029
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.029
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.029
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.029
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.029
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.029
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.029
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.029
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.029
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.029
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.029
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.028
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.028
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.028
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.028
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.028
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.028
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.028
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.028
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.028
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.028
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.028
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.027
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.027
|
|
|
|
regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060827 |
1 |
0.027
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.027
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.027
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.027
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.027
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.027
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.027
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.027
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.027
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.027
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.027
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.026
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.026
|
|
|
|
endocardial cushion development
|
GO:0003197 |
26 |
0.026
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.026
|
|